Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesEli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
A 64-year-old investor with a traditional IRA totaling $1.1 million pivots to three Dividend Kings to weather renewed...
Oracle’s latest quarterly results revived the debate around a potential oracle price prediction: $245 as cloud moment...
When a stock stalls, a disciplined fund can still see value in the long run. This article explains why this fund made...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
As energy demand grows, NuScale Power offers a potential long-term angle with small modular reactors. This guide expl...
A 2026 Trustees Report warns of a roughly 22% cut to Social Security benefits by late 2032 unless policy changes occu...
As AI workloads rise, memory stocks grab attention. This guide lays out three scenarios for where will micron stock b...
A Chinese AI model is reported to rival US leaders in performance, sparking a reassessment of investments in data cen...
Cardano’s Hoskinson reignites a long-running clash with Ethereum as investors weigh a fresh UTXO-style proposal. ETH ...
Fidelity’s 2026 retirement study reveals an 18-point confidence gap between men and women about retiring on their ter...